CEPF (NASDAQ:CEPF – Get Free Report) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totaling 7,113 shares, a growth of 92.1% from the September 15th total of 3,702 shares. Based on an average daily trading volume, of 123,962 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s shares are sold short.
CEPF Stock Performance
Shares of NASDAQ:CEPF traded down $0.01 on Wednesday, hitting $10.27. 198,440 shares of the company’s stock were exchanged, compared to its average volume of 82,045. The company has a market capitalization of $587.04 million, a PE ratio of 73.37 and a beta of 0.18. CEPF has a 1-year low of $10.13 and a 1-year high of $10.64. The firm’s 50-day moving average is $10.35 and its 200 day moving average is $10.33.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings cut shares of CEPF from a “sell (d)” rating to a “sell (d-)” rating in a report on Thursday, October 8th. One analyst has rated the stock with a Sell rating. According to MarketBeat, CEPF presently has a consensus rating of “Sell”.
CEPF Company Profile
Cantor Equity Partners IV, Inc (NASDAQ: CEPF) is a special purpose acquisition company (SPAC) formed to identify and combine with one or more businesses through a merger, acquisition, stock purchase or similar transaction.
As a SPAC, the company does not currently operate a traditional commercial business or offer its own products and services. Its primary activities are evaluating potential acquisition targets and completing a business combination. The company may pursue a target in a range of industries or geographic markets, subject to the terms of its formation documents and investor approval requirements.
Cantor Equity Partners IV is affiliated with Cantor Fitzgerald, a global financial services firm.
Further Reading
- Five stocks we like better than CEPF
- Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could Deepen
- Birkenstock’s Strong Growth Creates a Buying Opportunity
- High Voltage Returns: Navitas Rewires AI Data Centers
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
Receive News & Ratings for CEPF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEPF and related companies with MarketBeat.com's FREE daily email newsletter.
